Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name

Last Name

Company Name

Country

State

Agree to Subscribe & Privacy Policy*

*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.

Thank you!

Error - something went wrong!

No thanks

Get fast, non-stop, highly sensitive hit screening with Dianthus.

Dianthus removes the complexity of binding interaction measurements for drug discovery screening. Find hits for any target type in any buffer or bioliquid, measure the tightest interactions down to picomolar Kds, all by consuming the smallest amount of your target and library compounds. There’s no fluidics which means no regular maintenance and no downtime. With Dianthus, get the fastest time to meaningful results with no immobilization required. Learn more here: nanotempertech.com/dianthus Have a question?: nanotempertech.com/contact-specialist/

Because you demand fast, non-stop, highly sensitive hit screening.

Up next

Going small to win big: Fragment-based screening in drug discovery

Have a question about Dianthus?

Contact Specialist

Return to education center

A resource to help scientists learn more about protein characterization

Get fast, non-stop, highly sensitive hit screening with Dianthus.

Previous

Up next

Get fast, non-stop, highly sensitive hit screening with Dianthus.

Previous

Up next

See more related content

5,200 researchers, representing all of life sciences, gathered in San Diego in late January to discuss the latest in automation and screening solutions. Improvements in automation and screening...

Neurodegenerative diseases like Alzheimer’s or Parkinson’s Disease affect millions of people worldwide. Although current treatments may help relieve some of the physical or mental symptoms, there is s

Monoclonal antibodies (mAbs) have become the molecule of choice when highly specific molecular recognition is needed for a variety of applications including disease diagnosis and therapy....

A big hurdle in small molecule drug discovery screening is confidently identifying positive hits in a timely manner. Screening fragment libraries is challenging with current methodologies that are eit

Fragment-based drug discovery (FBDD) has become a major strategy to derive novel lead candidates in drug discovery. The principle of FBDD is to start with very small molecular fragments which may...

Almost all pharmaceutical drugs today act by binding to disease-causing proteins and inhibiting their activity. Unfortunately, there are still many target proteins — as much as 85% of the human...

Here’s how to make your trip unforgettable. 1. Immerse yourself in Liverpool’s historic heart at the Royal Albert Dock This is the place to be for many iconic Liverpool attractions. Discover...

Here’s how to make your trip memorable. 1. Be awe-inspired at La Sagrada Familia There’s nothing like it anywhere in the world. Architecture, nature and spirituality come together to create...

There’s a gap that exists in screening tools for drug discovery — the need for fast, easy to use and flexible devices isn’t being satisfied. Enter Dianthus, introduced to come to the rescue. At...

The famous painter Vincent Van Gogh once said, “Great things are done by a series of small things brought together.” This is exactly how drugs are developed by means of fragment-based screening —...

PRESS RELEASE SOUTH SAN FRANCISCO, Calif. NanoTemper Technologies, maker of life science tools for protein characterization, launches its newest system, Dianthus, at the Society for Laboratory...